Literature DB >> 9456011

Effect of medication on biomechanical properties of rabbit bones: heparin induced osteoporosis.

N Akkas1, Y N Yeni, B Turan, E Delilbasi, U Gunel.   

Abstract

The aim of this controlled study is to investigate the effect of heparin on osteoporosis initiation and of calcitonin and tamoxifen on the progress of osteoporosis induced by heparin through biomechanical means and, thus, to assist in clinical usage of these drugs. 32 four-month-old female New Zealand white rabbits were divided into four different experimental groups. The animals in group A were administered heparin (Liquemine) intraperitoneally at the dosage of 1000 IU/kg/day. The animals in group B were injected the same amount of heparin as those of group A, and in addition, were given calcitonin at the dosage of 100 IU/kg/day. The animals in group C were medicated the same way as group B but 2 mg/kg/day tamoxifen (Nolvadex) was orally added into their intestine via cannula, one side connected to the injector. The animals in group D were the control. The experiment lasted 8 weeks. The animals in all experimental groups showed the same growth pattern as that of the control group. Whole-bone femur, humerus and tibia specimens were subjected to 3-point bending tests while sections from the proximal ends of the same specimens were subjected to compression tests. The data, recorded as load vs deflection, were converted into stress vs strain using the strength of materials formulae. The data obtained from the bending and the compression experiments were treated separately. The stiffness of the bones of the medicated groups were compared with those of the control groups. Our data indicated that the tamoxifen treated humera, femora and tibiae attained the largest bending stiffness in all cases investigated. However, this was not the case for compression. None of the drug administered groups attained the stiffness of the control group except for the case of tamoxifen treated femora which attained stiffness close to that of the controls. The results show that heparin altered the mechanical properties of bones indicating osteoporosis, tamoxifen was effective in reducing the effect of heparin while calcitonin yielded no conclusive result.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9456011     DOI: 10.1007/bf02247799

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  49 in total

1.  Nasal calcitonin for treatment of established osteoporosis.

Authors:  K Overgaard; B J Riis; C Christiansen; J Pødenphant; J S Johansen
Journal:  Clin Endocrinol (Oxf)       Date:  1989-04       Impact factor: 3.478

Review 2.  Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy.

Authors:  L V Avioli
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

3.  Stiffness of compact bone: effects of porosity and density.

Authors:  M B Schaffler; D B Burr
Journal:  J Biomech       Date:  1988       Impact factor: 2.712

4.  Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

Authors:  G F Mazzuoli; M Passeri; C Gennari; S Minisola; R Antonelli; C Valtorta; E Palummeri; G F Cervellin; S Gonnelli; G Francini
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

5.  Effects of anti-estrogens on bone in castrated and intact female rats.

Authors:  V C Jordan; E Phelps; J U Lindgren
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

6.  Effect of (Asu1,7)-eel calcitonin on the prevention of osteoporosis induced by combination of immobilization and ovariectomy in the rat.

Authors:  T Hayashi; T Yamamuro; H Okumura; R Kasai; K Tada
Journal:  Bone       Date:  1989       Impact factor: 4.398

7.  Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis.

Authors:  T Nishioka; H Kurayama; T Yasuda; J Udagawa; C Matsumura; H Niimi
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

8.  Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.

Authors:  T Fornander; L E Rutqvist; H E Sjöberg; L Blomqvist; A Mattsson; U Glas
Journal:  J Clin Oncol       Date:  1990-06       Impact factor: 44.544

9.  Heparin-induced osteoporosis in rats.

Authors:  T Mätzsch; D Bergqvist; U Hedner; B Nilsson; P Ostergaard
Journal:  Thromb Haemost       Date:  1986-12-15       Impact factor: 5.249

10.  Temporal relationship between bone loss and increased bone turnover in ovariectomized rats.

Authors:  T J Wronski; M Cintrón; L M Dann
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

View more
  2 in total

1.  Selenium combined with vitamin E and vitamin C restores structural alterations of bones in heparin-induced osteoporosis.

Authors:  Belma Turan; Belgin Can; Ertan Delilbasi
Journal:  Clin Rheumatol       Date:  2003-10-31       Impact factor: 2.980

2.  Effect of a direct thrombin inhibitor compared with dalteparin and unfractionated heparin on human osteoblasts.

Authors:  Tobias Winkler; Carsten Perka; Dörte Matziolis; Georg Matziolis
Journal:  Open Orthop J       Date:  2011-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.